ETICIA Protocol Trial

Phase 2

Not yet recruiting

• Conditions: Haematological Disorders; Paediatrics; Iron Deficiency Anaemia

• Registration Number: PACTR201908553469676
• Lead Sponsor: awrence Osei Tutu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-31
• Last Update Posted: 2023-05-29

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Inclusion Criteria include the following:
Children 6 – 59 months;
Hb between 40 and < 70g/L at the time of screening as measured by an automated haematology analyser;
Haemodynamically compensated or stable, not urgently requiring RBC transfusion;
Not critically ill and needing urgent intensive care and/or surgery; and
No evidence of ongoing blood loss (overtly or per facility’s standards for occult blood loss diagnosis), haemolysis (normal urobilinogen levels on urine dipstick examination), infections and temperature spikes (blood culture positive and on antibiotics)

Exclusion Criteria

Exclusion Criteria include the following:
Acute phase of management for severe acute malnutrition, severe malaria and/or severe bacterial infection or sepsis requiring parenteral antibiotics;
Haemodynamically unstable; heart failure, ongoing haemolysis or bleeding, on chemotherapy, aplastic anaemia;
Surgery within 14 days of hospitalisation;
Unable to take food or medications orally; and
Recipient of chronic blood transfusion therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified